Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-05-11 Purchase |
2020-05-12 8:45 pm |
Tricida Inc. | TCDA | Parker Geoffrey M. Chief Fin. Officer and EVP |
35,000 | $30.09 | $1,053,203 | 231,165 (Indirect Direct) |
View |
| 2020-05-08 Sale |
2020-05-12 8:38 pm |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
3,000 | $31.98 | $95,940 | 43,284 (Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 5:33 pm |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
1,250 | $30.14 | $37,680 | 22,098 (Direct) |
View |
| 2020-05-01 Sale |
2020-05-04 5:34 pm |
Tricida Inc. | TCDA | KLAERNER GERRIT President and CEO |
4,000 | $27.98 | $111,906 | 592,644 (Indirect Direct) |
View |
| 2020-04-28 Sale |
2020-04-30 4:33 pm |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
4,250 | $31.39 | $133,415 | 55,096 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-05-08 Exercise |
2020-05-12 8:38 pm |
N/A 2026-09-26 |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
3,000 | $0 | 43,284 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 8:38 pm |
N/A N/A |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
1,040 | $1.68 | 43,284 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 8:38 pm |
N/A N/A |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
1,437 | $2.39 | 43,284 (Direct) |
View |
| 2020-05-08 Exercise |
2020-05-12 8:38 pm |
N/A N/A |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
523 | $7.49 | 43,284 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 5:33 pm |
N/A 2026-11-02 |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
1,250 | $0 | 22,098 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 5:33 pm |
N/A N/A |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
798 | $1.68 | 22,098 (Direct) |
View |
| 2020-05-05 Exercise |
2020-05-07 5:33 pm |
N/A N/A |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
452 | $2.39 | 22,098 (Direct) |
View |
| 2020-04-28 Exercise |
2020-04-30 4:33 pm |
N/A 2026-11-02 |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
4,250 | $0 | 55,096 (Direct) |
View |
| 2020-04-28 Exercise |
2020-04-30 4:33 pm |
N/A N/A |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
3,204 | $1.68 | 55,096 (Direct) |
View |
| 2020-04-29 Exercise |
2020-04-30 4:33 pm |
N/A N/A |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
523 | $2.39 | 55,096 (Direct) |
View |
| 2020-04-29 Exercise |
2020-04-30 4:33 pm |
N/A N/A |
Tricida Inc. | TCDA | Otto Dawn Parsell EVP, Clinical Development |
523 | $7.49 | 55,096 (Direct) |
View |